Abnormal IFNG-AS1 and GAS5 expression levels have been linked to a number of autoimmune disorders, implying that these genes may play a role in the pathogenesis of autoimmunity and could represent new targets of therapy (Wu et al., 2017), (Peng et al., 2020a). This evidence concerns the gene GAS5 and autoimmune disease.